russ2000_2_0684|XFOR|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0684|XFOR|Long Name|X4 Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|X4 Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|X4 Pharmaceuticals Inc Inventories (Quarterly) (USD)|X4 Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|X4 Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|X4 Pharmaceuticals Inc Book Value (Quarterly) (USD)|X4 Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|X4 Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|X4 Pharmaceuticals Inc EV to Revenues|X4 Pharmaceuticals Inc EV to Earnings|X4 Pharmaceuticals Inc EV to Free Cash Flow|X4 Pharmaceuticals Inc EV to Assets (Quarterly)|X4 Pharmaceuticals Inc PS Ratio|X4 Pharmaceuticals Inc PE Ratio|X4 Pharmaceuticals Inc Price to Book Value|X4 Pharmaceuticals Inc PEG Ratio|X4 Pharmaceuticals Inc Debt to Equity Ratio|X4 Pharmaceuticals Inc Dividend Yield|X4 Pharmaceuticals Inc Shareholder Yield (TTM)|X4 Pharmaceuticals Inc Percent of Shares Outstanding Short|X4 Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Payables (Quarterly) (USD)|X4 Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|X4 Pharmaceuticals Inc Return on Invested Capital|X4 Pharmaceuticals Inc Quality Ratio Score|X4 Pharmaceuticals Inc Momentum Score|X4 Pharmaceuticals Inc Beta (1Y)|X4 Pharmaceuticals Inc Sustainable Growth Rate (TTM)|X4 Pharmaceuticals Inc Institutional Investor Ownership Percentage|X4 Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|X4 Pharmaceuticals Inc Total Employees (Annual)|X4 Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|X4 Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|X4 Pharmaceuticals Inc Revenue (Quarterly) (USD)|X4 Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|X4 Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|X4 Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|X4 Pharmaceuticals Inc Net Income (Quarterly) (USD)|X4 Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|X4 Pharmaceuticals Inc Price (USD)|X4 Pharmaceuticals Inc Total Return Price (USD)|X4 Pharmaceuticals Inc Enterprise Value (USD)|X4 Pharmaceuticals Inc 30-Day Average Daily Volume|X4 Pharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0684|XFOR|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0684|XFOR|201612|5.716|3.035||0.519||64.166|12.06|52.106||-56.562|-58.388||||||||||||||1.345|1.645|0.001|||||||0.928||-5.7403||||1.473|-5.321|-5.321|-0.792|||||||
russ2000_2_0684|XFOR|201703||||||||||||||||||||||||||||||||||0.928||-5.8103||||1.436|-5.385|-5.385|-1.019|||||||
russ2000_2_0684|XFOR|201706||||||||||||||||||||||||||||||||||0.928||-6.1616||||1.738|-5.705|-5.705|-0.444|||||||
russ2000_2_0684|XFOR|201709|33.268|26.254||0.479||25.562|13.254|12.308||11.6|-81.078||||||||||||||1.454|4.164|0.008|||||||1.8032|39|-6.4418||||2.455|-11.6|-11.6|-0.253||||||84.18|84.18
russ2000_2_0684|XFOR|201712|79.53|76.793||0.421||22.547|10.68|11.867||58.707|-92.265||||||||14.934|||0||0.3484|1.608|1.893|0.015|||||||2.3824|40|-10.08||||2.376|-11.187|-11.187|-0.149|76.56|76.56|161.0045|65436.4667||81.9|81.9
russ2000_2_0684|XFOR|201803|68.525|63.999||0.384||20.798|9.297|11.501||48.423|-102.895||||-8.805||||5.2861|||0||1.1897|1.926|1.108|0.015|||||||2.3824||-4.44||||2.817|-10.63|-10.63|-0.051|130.26|130.26|285.6558|56143.1667||140.82|140.82
russ2000_2_0684|XFOR|201806|56.562|49.94||0.353||19.446|10.214|9.232||37.764|-115.028||||-5.7055||||5.3815|||0||1.7152|2.178|2.137|0.014|||||||2.384||-5.1||||3.686|-12.133|-12.133|-0.034|109.38|109.38|208.0321|38767.8||23.1|23.1
russ2000_2_0684|XFOR|201809|44.934|40.753||0.323||18.004|8.853|9.151||27.897|-125.928||||0.3561||||0.6217|||0||1.0347|2.87|2.126|0.014|||||||2.3859||-4.56||||3.275|-10.9|-10.9|-0.063|9.84|9.84|-15.5571|175807.2||9.54|9.54
russ2000_2_0684|XFOR|201812|35.08|30.754||0.285||14.404|5.398|9.006||21.6|-135.286||||-0.0867|0.3041|||1.5652||0.3655|0||4.2025|2.859|0.545|0.015|||1|1.9578|||2.3863|15|-3.96||3.5||8.628|-9.358|-9.358|-0.082|16.08|16.08|4.0527|3589813.5|-81.8182|15.36|15.36
russ2000_2_0684|XFOR|201903|26.223|22.299||2.975|32.307|33.108|16.45|16.658||29.441|-90.11||||-2.2994|1.8136|||6.1971||0.6339|0||1.2941|1.552|6.132|0.007|||1|3.4057|||1.718||-6.67||||4.783|-10.873|-10.873|-0.33|18.47|18.47|94.13|18735.5|-87.3234|17.72|17.72
russ2000_2_0684|XFOR|201906|96.649|90.18||2.445|32.009|37.339|13.204|24.135||96.168|-103.493||||-4.396|0.915|||6.1722||0.2693|0||1.3071|1.708|3.099|0.013|||1|3.0219|||13.177||-1.02||||4.56|-13.383|-13.383|-0.118|14.67|14.67|178.0803|29074.6|-37.5|15.55|15.55
russ2000_2_0684|XFOR|201909|79.215|76.251||2.458|27.109|30.43|8.279|22.151||79.107|-121.207|||-1.9833|-2.1032|0.9294|||1.5718||0.2526|0|-0.3955|1.8478|1.73|1.704|0.012|-68.7218||8|3.5013|-100.9547||14.562||-1.22||||4.383|-17.714|-17.714|-0.224|12.27|12.27|86.8727|41222.8333|30.7613|12.43|12.43
russ2000_2_0684|XFOR|201912|129.278|126.184||2.362|27.109|31.478|9.447|22.031||129.22|-132.044|||-1.2592|-1.3787|0.4138|||1.3355||0.1555|0|-0.2302|1.0241|1.998|2.088|0.016|-58.9265||2|2.0141|-74.2639||16.522|58|-0.66||||3.914|-10.837|-10.837|-0.278|10.95|10.95|66.4922|118468.1|-23.1322|10.95|10.95
russ2000_2_0684|XFOR|202003|121.95|115.054||2.278|27.109|34.926|7.95|26.976||118.791|-143.182|||-1.3497|-1.3628|0.466|||1.3588||0.2127|0|-88.5041|1.2995|3.416|1.248|0.016|-47.1635||3|-0.1684|-58.6137||20.014||-0.56||3||4.67|-10.99|-11.138|-0.288|9.5|9.5|71.631|78307.8667|-42.5617|8.17|8.17
russ2000_2_0684|XFOR|202006|109.887|103.744||2.065|27.109|37.65|10.781|26.869||104.884|-158.326|||-1.3645|-1.4563|0.4711|||1.4374|||0||1.2124|0.509|1.838|0.016|||3|-0.7589|||20.032||-0.76||||5.316|-15.144|-15.144|-0.68|9.72|9.72|72.4162|89147.5333|-37.8667|9.11|9.11
russ2000_2_0684|XFOR|202009|||||||||||||||-0.591||||1.0272|||0||1.9017||||||3|-0.391||95.9714|||||||||||6.77|6.77|29.3875|105942.8667|-46.7349|7.01|7.01